Alligator’s CMO hosts in-depth webinar on Mitazalimab

At the beginning of the year, Alligator BioScience presented promising interim data from its OPTIMIZE-1 phase II study in metastatic pancreatic cancer.

To put further emphasis on the study design and importance of these results, the Swedish biotech hosted a webinar featuring Alligator’s CMO Sumeet Ambarkhane and Jean-Luc Van Laethem, who is Principal Investigator for.